Critically Ill
Conditions
Keywords
Critically ill, nutrition, randomised controlled clinical trial, human, adult, Supplemental parenteral nutrition
Brief summary
Rationale: Enteral nutrition (EN) in the intensive care (ICU) patients is recommended as a standard of care. However, EN alone is often associated with insufficient energy intakes and increased complication rates. Recently the investigators proposed to decrease this deficit by combining EN and supplemental parenteral nutrition (SPN) whenever EN is insufficient (\< 60% of their predicted energy needs) at day 3 after admission in the ICU. Objective: This study aims at: a/ investigating if the delivery of optimal nutrition support (100 % of predicted energy targets) in ICU patients by the combined administration of SPN and EN optimizes their clinical outcome; b/ implementing the new ICU nutrition guidelines. Study design: Prospective, controlled, randomized clinical study. Study site: Service of Intensive Care, Geneva University Hospital. Patient population: 220 ICU patients to be included: expected length of stay \> 5 days, expected survival \> 7 days, no contraindication to EN, obtained informed consent from themselves or their next of keen. Exclusion criteria: refusal of consent, age \< 18 years, short bowel syndrome, significant persistent gastrointestinal dysfunction with ileus, high output proximal fistula (\> 1,5 liter/d), patients receiving PN. Nutrition: At day 3 after admission, if energy input is \< 60%; patients are randomized into either the Control group (EN alone) or the SPN group (EN + PN) to reach 100% of their predicted energy needs. Tight glycaemic control (target 6.0 to 8.3 mmol/l) to be achieved according to our local practice by insulin administration. Study endpoints: * Primary: nosocomial infections (CDC criteria) * Secondary: Mechanical ventilation duration, ICU and hospital length of stay, antibiotic free days, ICU complications (extra-renal epuration, neurological, cardiac and respiratory complications), energy and protein balance, 28 days clinical outcome.
Detailed description
Introduction: Nutritional support of the intensive care (ICU) patients is recommended as a standard of care. It is also strongly recommended to start enteral feeding as soon as possible whenever the gastrointestinal tract is functioning (1). However, studies have repeatedly shown that with enteral support alone, insufficient energy and protein intakes often occur (2). The resulting energy and protein deficit is associated with an increased complication rate in ICU patients (3-5). Recently we proposed to decrease this deficit by promoting a combined nutrition support by enteral nutrition (EN) and supplemental parenteral nutrition (SPN) whenever EN is insufficient (6). Contrary to former beliefs, recent meta-analyses show that parenteral nutrition (PN) does not carry excess mortality (7, 8). These reports convey a concept that is a major break-through in current routine of nutritional support in ICU patients by promoting a much wider use of PN. SPN could be the optimal modality to provide the calculated energy targets if this cannot be reached by EN alone. To improve ICU patient's outcome and minimise complications, we propose to implement feeding protocols which combine both EN and PN, when EN is insufficient to cover more than 60% of caloric needs at day 4 to reach 100% of the energy targets by adding PN from day 4 (6). Hypothesis: The administration of SPN, in ICU patients receiving \< 60% of targeted energy needs by EN alone, has a positive impact on their clinical outcome by optimising their nutritional support (reduced infectious complications rate, mechanical ventilation days, duration of ICU and hospital length of stay and rehabilitation). Objective: The aim of the present study is to investigate if the delivery of optimal nutrition support (100 % of predicted energy targets) in ICU patients achieved with the combined administration of SPN and EN optimizes their clinical outcome.
Interventions
SPN : in the treated group, SPN is started if at day 4 energy input by EN is \< 60% of energy target in order to reach 100% of energy target by peripheral or central line.
Sponsors
Study design
Eligibility
Inclusion criteria
* Expected ICU stay \> 5 days * Expected survival \> 7 days * No contraindication to EN * Obtained informed consent
Exclusion criteria
* Refusal of consent * Age \< 18 years * Short bowel syndrome * Significant persistent gastrointestinal dysfunction with ileus * High output proximal fistula (\> 1.5 liter/d) * Patients receiving PN
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Documented Infection Rate | 20 days | Infection, defined according to CDC criteria during the ICU and hospital stay, occurrence between day 9 and day 28 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Antibiotic Free Days | 20 days | Number of days between day 9 to day 28 (follow-up period) free of antibiotics |
| Total Energy Intake During the Intervention Period , Between Day 4 and Day 8. | 5 days | Percentage of energy target; in the SPN group the goal was to achieve 100% of the energy target during intervention (day 4 to day 8.The energy target was measured by indirect calorimetry in 198 patients of 305(65%),otherwise energy target was calculated by 25 kcal per kg of ideal body weight for women and 30 kcal per kg of ideal body weight for men and anamnestic body weight was used for patients with a body mass index of 20 kg/m2 or lower. |
| General Mortality | 28 days | — |
| Hours on Mechanical Ventilation in All Patients | 28 days | Mechanical ventilation hours during study duration (days 1-28) |
| ICU Mortality | 28 days | — |
| Protein Delivery During the Intervention Period From Day 4 to Day 8 | 5 days | Percentage of protein target between day 4 to 8. Protein target was set to 1.2 g per kg of ideal body weight a day. |
| Days in Hospital | 28 days | hospital length of stay |
| Days in ICU | 28 days | Days in ICU |
Countries
Switzerland
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Control gr EN : start EN at 20-30 ml/h per day up to maximal 150 ml/h per day; or day1: 500 ml, day2: 1000 ml, day3: 1500 ml of EN dependant on gastrointestinal tolerance (gastric residue volume more than 500ml). Nutritional products as currently used in our institution. | 152 |
| SPN Group experimental arm: Supplemental Parenteral Nutrition (SPN) is added to enteral nutrition (EN) to reach 100% of their predicted energy needs from ICU day 4.
In the treated group, SPN is started if at day 4 energy input by EN is \< 60% of energy target in order to reach 100% of energy target by peripheral or central line. Nutritional products as currently used in our institution. SPN is composed of EN and PN, both techniques being currently used in our institution.
SPN : SPN : in the treated group, SPN is started if at day 4 energy input by EN is \< 60% of energy target in order to reach 100% of energy target by peripheral or central line. | 153 |
| Total | 305 |
Baseline characteristics
| Characteristic | SPN Group | Control gr | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 70 Participants | 61 Participants | 131 Participants |
| Age, Categorical Between 18 and 65 years | 83 Participants | 91 Participants | 174 Participants |
| Age Continuous | 61 years STANDARD_DEVIATION 16 | 60 years STANDARD_DEVIATION 16 | 60 years STANDARD_DEVIATION 17 |
| Region of Enrollment Switzerland | 153 participants | 152 participants | 305 participants |
| Sex: Female, Male Female | 43 Participants | 47 Participants | 90 Participants |
| Sex: Female, Male Male | 110 Participants | 105 Participants | 215 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 152 | 0 / 153 |
| serious Total, serious adverse events | 0 / 152 | 0 / 153 |
Outcome results
Documented Infection Rate
Infection, defined according to CDC criteria during the ICU and hospital stay, occurrence between day 9 and day 28
Time frame: 20 days
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Control gr | Documented Infection Rate | 58 Infections |
| SPN Group | Documented Infection Rate | 41 Infections |
Antibiotic Free Days
Number of days between day 9 to day 28 (follow-up period) free of antibiotics
Time frame: 20 days
Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).
| Arm | Measure | Value (MEAN) |
|---|---|---|
| Control gr | Antibiotic Free Days | 12 number of days |
| SPN Group | Antibiotic Free Days | 14 number of days |
Days in Hospital
hospital length of stay
Time frame: 28 days
Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).
| Arm | Measure | Value (MEAN) |
|---|---|---|
| Control gr | Days in Hospital | 32 days in hospital |
| SPN Group | Days in Hospital | 31 days in hospital |
Days in ICU
Days in ICU
Time frame: 28 days
Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).
| Arm | Measure | Value (MEAN) |
|---|---|---|
| Control gr | Days in ICU | 13 days in ICU |
| SPN Group | Days in ICU | 13 days in ICU |
General Mortality
Time frame: 28 days
Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).
| Arm | Measure | Value (NUMBER) | Dispersion |
|---|---|---|---|
| Control gr | General Mortality | 28 participants | 18 |
| SPN Group | General Mortality | 20 participants | 13 |
Hours on Mechanical Ventilation in All Patients
Mechanical ventilation hours during study duration (days 1-28)
Time frame: 28 days
Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).
| Arm | Measure | Value (MEAN) |
|---|---|---|
| Control gr | Hours on Mechanical Ventilation in All Patients | 166 hours of mechanical ventilation |
| SPN Group | Hours on Mechanical Ventilation in All Patients | 153 hours of mechanical ventilation |
ICU Mortality
Time frame: 28 days
Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Control gr | ICU Mortality | 12 participants |
| SPN Group | ICU Mortality | 8 participants |
Protein Delivery During the Intervention Period From Day 4 to Day 8
Percentage of protein target between day 4 to 8. Protein target was set to 1.2 g per kg of ideal body weight a day.
Time frame: 5 days
Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control gr | Protein Delivery During the Intervention Period From Day 4 to Day 8 | 71 percentage of protein target | Standard Deviation 27 |
| SPN Group | Protein Delivery During the Intervention Period From Day 4 to Day 8 | 100 percentage of protein target | Standard Deviation 16 |
Total Energy Intake During the Intervention Period , Between Day 4 and Day 8.
Percentage of energy target; in the SPN group the goal was to achieve 100% of the energy target during intervention (day 4 to day 8.The energy target was measured by indirect calorimetry in 198 patients of 305(65%),otherwise energy target was calculated by 25 kcal per kg of ideal body weight for women and 30 kcal per kg of ideal body weight for men and anamnestic body weight was used for patients with a body mass index of 20 kg/m2 or lower.
Time frame: 5 days
Population: The intention to treat analysis included all patients randomly assigned to the intervention SPN group (153) or control group EN (152). The per protocol analysis included only patients who fully completed the 5-day intervention in the ICU (SPN group(133); EN group (142).
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Control gr | Total Energy Intake During the Intervention Period , Between Day 4 and Day 8. | 77 % of energy target | Standard Deviation 27 |
| SPN Group | Total Energy Intake During the Intervention Period , Between Day 4 and Day 8. | 103 % of energy target | Standard Deviation 18 |